Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488083/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591615223398400 |
|---|---|
| author | Bin Zhang Bin Zhang Bin Zhang Bin Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Jingxue Ye Shihuan Kuang Guibo Sun Guibo Sun Guibo Sun Guibo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun |
| author_facet | Bin Zhang Bin Zhang Bin Zhang Bin Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Jingxue Ye Shihuan Kuang Guibo Sun Guibo Sun Guibo Sun Guibo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun |
| author_sort | Bin Zhang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-2634df6f60f14cfc9b18c4b8fd7e8453 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-2634df6f60f14cfc9b18c4b8fd7e84532025-01-22T08:14:47ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14880831488083Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signalingBin Zhang0Bin Zhang1Bin Zhang2Bin Zhang3Jingyi Zhang4Jingyi Zhang5Jingyi Zhang6Jingyi Zhang7Chenyang Zhang8Chenyang Zhang9Chenyang Zhang10Chenyang Zhang11Xuelian Zhang12Xuelian Zhang13Xuelian Zhang14Xuelian Zhang15Jingxue Ye16Shihuan Kuang17Guibo Sun18Guibo Sun19Guibo Sun20Guibo Sun21Xiaobo Sun22Xiaobo Sun23Xiaobo Sun24Xiaobo Sun25Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, ChinaInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, ChinaInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, ChinaInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, ChinaInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Animal Sciences, Purdue University, West Lafayette, IN, United StatesInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, ChinaInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaKey Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, ChinaBeijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Beijing, ChinaKey Laboratory of Efficacy Evaluation of Chinese Medicine Against Glyeolipid Metabolism Disorder Disease, State Administration of Traditional Chinese Medicine, Beijing, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2024.1488083/fulldiabetes mellitusdiabetic cardiomyopathyestrogen receptorapoptosisoxidative stress |
| spellingShingle | Bin Zhang Bin Zhang Bin Zhang Bin Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Jingyi Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Chenyang Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Xuelian Zhang Jingxue Ye Shihuan Kuang Guibo Sun Guibo Sun Guibo Sun Guibo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun Xiaobo Sun Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling Frontiers in Pharmacology diabetes mellitus diabetic cardiomyopathy estrogen receptor apoptosis oxidative stress |
| title | Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| title_full | Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| title_fullStr | Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| title_full_unstemmed | Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| title_short | Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| title_sort | corrigendum notoginsenoside r1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling |
| topic | diabetes mellitus diabetic cardiomyopathy estrogen receptor apoptosis oxidative stress |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488083/full |
| work_keys_str_mv | AT binzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT binzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT binzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT binzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT jingyizhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT jingyizhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT jingyizhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT jingyizhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT chenyangzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT chenyangzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT chenyangzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT chenyangzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xuelianzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xuelianzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xuelianzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xuelianzhang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT jingxueye corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT shihuankuang corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT guibosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT guibosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT guibosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT guibosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xiaobosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xiaobosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xiaobosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling AT xiaobosun corrigendumnotoginsenosider1protectsagainstdiabeticcardiomyopathythroughactivatingestrogenreceptoraanditsdownstreamsignaling |